Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers F > Headlines for Flexion Therapeutics Inc. > News item |
Flexion announces plans to price its initial public offering of stock
BMO Capital Markets, Wells Fargo Securities to assist as bookrunners
By Devika Patel
Knoxville, Tenn., Jan. 8 - Flexion Therapeutics Inc. will conduct an initial public sale of its common stock with a greenshoe option, according to a Form S-1 filed Wednesday with the Securities and Exchange Commission.
BMO Capital Markets and Wells Fargo Securities are the joint bookrunning managers.
Proceeds will be used for clinical development, clinical trials, working capital and other general corporate purposes.
The Burlington, Mass., specialty pharmaceutical company develops injectable pain therapies. It intends to list its common stock on the Nasdaq under the symbol "FLXN."
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.